0.89
-0.0094(-1.04%)
Currency In USD
| Previous Close | 0.9 |
| Open | 0.9 |
| Day High | 0.91 |
| Day Low | 0.86 |
| 52-Week High | 5.12 |
| 52-Week Low | 0.85 |
| Volume | 330,530 |
| Average Volume | 192,443 |
| Market Cap | 37.85M |
| PE | -2.07 |
| EPS | -0.43 |
| Moving Average 50 Days | 1.48 |
| Moving Average 200 Days | 2.2 |
| Change | -0.01 |
If you invested $1000 in Elutia Inc. (ELUT) since IPO date, it would be worth $61.43 as of October 19, 2025 at a share price of $0.891. Whereas If you bought $1000 worth of Elutia Inc. (ELUT) shares 3 years ago, it would be worth $127.06 as of October 19, 2025 at a share price of $0.891.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21
GlobeNewswire Inc.
Oct 14, 2025 8:05 PM GMT
GAITHERSBURG, Md., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, President and Chief Executive Officer, will present at the LD Micro
Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors
GlobeNewswire Inc.
Oct 10, 2025 12:00 PM GMT
Industry leader brings 40 years of executive and board experience across the global medical technology sector GAITHERSBURG, Md., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting bio
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million
GlobeNewswire Inc.
Oct 01, 2025 12:41 PM GMT
- Strengthened balance sheet to fully fund development and launch of NXT-41 platform - - Biologics for breast reconstruction represents $1.5 billion U.S. total addressable market - GAITHERSBURG, Md., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (N